SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oncolytics Reports About 15-Month Median Response Duration in Anal Cancer Trial

Oncolytics reported an about 15-month median response duration for a pelareorep combination in an anal cancer trial.

ONCY

Related stories